26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

II. Anterior Lobe and Intermediate Lobe<br />

581<br />

Plasma IGF-I exerts a negative feedback <strong>of</strong> GH release<br />

both at the hypothalamic level where it stimulates SS release<br />

and inhibits GHRH release, as well as at the pituitary level.<br />

As the majority <strong>of</strong> plasma IGF-I is bound to specific binding<br />

proteins, in plasma predominantly IGFBP3, the free rather<br />

than the protein-bound IGF-I determines these feedback<br />

regulations ( Chen et al. , 2005 ). The elevated GH concentrations<br />

in fasting dogs have also been explained as the result<br />

<strong>of</strong> impaired feedback inhibition caused by low IGF-I plasma<br />

levels ( Eigenmann et al. , 1985 ).<br />

Finally thyroid hormone, sex steroids, and glucocorticoids<br />

modulate GH synthesis and release. In contrast to<br />

humans and rats where low plasma thyroid hormone concentrations<br />

result in attenuated GH secretion, hypothyroidism<br />

in the dog is associated with enhanced basal plasma GH<br />

concentrations and reduced pulsatility ( Lee et al. , 2001 ). In<br />

dogs with pituitary-dependent hyperadrenocorticism, no differences<br />

exist in the basal plasma GH secretion, but less GH<br />

is secreted in pulses in comparison to control dogs ( Hanson<br />

et al. , 2006a ; Lee et al. , 2003 ). In dogs, endogenous and<br />

exogenous progestins may induce considerable rises in<br />

plasma growth hormone concentrations, resulting in acromegalic<br />

changes and insulin resistance ( Rijnberk et al. , 2003 ;<br />

Selman et al. , 1994a ; Selman et al. , 1994b ).<br />

e . Action<br />

The effects <strong>of</strong> GH can be divided into two main categories:<br />

rapid or metabolic actions and slow or hypertrophic<br />

actions. The (acute) metabolic responses are due<br />

to direct interaction <strong>of</strong> growth hormone with the target<br />

cell, whereas the slow hypertrophic effects or those on<br />

cartilage, bone, and other tissues are indirect. The direct<br />

effects <strong>of</strong> GH result in differentiation <strong>of</strong> prechondrocytes,<br />

enhanced lipolysis in adipose tissue, increased gluconeogenesis,<br />

and restricted glucose transport caused by insulin<br />

resistance ( Eigenmann, 1984 ; Renaville et al. , 2002 ;<br />

Veldhuis et al. , 2006 ). The GH responsiveness <strong>of</strong> adipose<br />

tissue is less dependent on nutrition than that <strong>of</strong> the liver,<br />

which may explain the reduced adiposity in the absence<br />

<strong>of</strong> growth enhancement in GH-treated ruminants ( Breier<br />

et al. , 1986 ). In vitro GH has also a direct positive effect<br />

on the maturation <strong>of</strong> bovine oocytes ( Bevers and Izadyar,<br />

2002 ) and human hematolymphopoiesis ( Hanley et al. ,<br />

2005 ).<br />

In contrast to these direct catabolic effects, the indirect<br />

actions are anabolic and mediated by the insulin-like<br />

growth factors IGF-I and IGF-II ( Daughaday et al. , 1987 ).<br />

In their chemical structure the IGFs have approximately<br />

50% homology with insulin/proinsulin, suggesting they<br />

have evolved from a common ancestral molecule. The IGFs<br />

are bound to a family <strong>of</strong> six different high-affinity IGFbinding<br />

proteins ( Firth and Baxter, 2002 ). The main<br />

IGFBP in plasma is IGFBP3, which forms together with<br />

an acid-labile subunit a ternary complex <strong>of</strong> 150 kDa. As a<br />

consequence, IGFs have a long plasma half-life, which is<br />

consistent with their long-term growth promoting action.<br />

Specific proteolysis may increase free IGF concentration<br />

locally and modulates the IGF receptor signaling ( Bunn<br />

and Fowlkes, 2003 ).<br />

Dogs have an extreme variation <strong>of</strong> body size between<br />

breeds. It has been shown that a large body size is associated<br />

with GH excess at a young age ( Favier et al. , 2001 ).<br />

In adult dogs, circulating IGF-I concentrations were<br />

found to correlate with body size in different dog breeds<br />

( Eigenmann et al. , 1988 ). By studying genetic subgroups<br />

within one breed (i.e., standard, miniature, and toy poodles),<br />

plasma IGF-I concentrations, and not GH secretory<br />

reserve, did parallel body size ( Eigenmann et al. , 1984a ).<br />

f . Disease<br />

Inadequate growth hormone secretion at a young age retards<br />

growth. Apart from occasional reports on dwarfism in dogs<br />

and cats, GH-deficiency dwarfism seems to occur primarily<br />

as a genetically transmitted condition in the German<br />

Shepherd ( Andresen et al. , 1974 ) and in the Carelian bear<br />

dog ( Andresen and Willeberg, 1977 ). In the German shepherd,<br />

the GH deficiency is associated with TSH and prolactin<br />

deficiency and impaired LH and FSH release without disturbances<br />

in ACTH secretion ( Kooistra et al. , 2000c ). This<br />

indicates that at a defect in the organogenesis <strong>of</strong> the pituitary<br />

resulting from mutation in an essential transcription<br />

factor may have occurred. So far the involvement <strong>of</strong> mutations<br />

in Pit-1 ( Lantinga-van Leeuwen et al. , 2000b ), Prop1<br />

(Lantinga-van Leeuwen et al. , 2000a ), LHX4 ( van Oost et al. ,<br />

2002 ), and the LIF receptor ( Hanson et al. , 2006b ) has been<br />

excluded as candidate genes for pituitary dwarfism.<br />

In adults, growth hormone deficiency causes much less<br />

impressive changes. The clinical features remain confined<br />

to the skin and coat. Affected dogs are presented with<br />

alopecia and hyperpigmentation <strong>of</strong> the skin. In contrast<br />

to dogs with congenital hyposomatotropism, these dogs<br />

may have low but detectable plasma GH concentrations,<br />

a blunted response to a clonidine or GHRH stimulation<br />

test, but plasma IGF-I concentrations within the reference<br />

range. This may be caused by a mild and fluctuating<br />

hyperadrenocorticism ( Rijnberk et al. , 1993 ). In some dogs<br />

the alopecia was explained by an adrenal androgen imbalance.<br />

Among other treatments, administration <strong>of</strong> GH has<br />

been associated with hair regrowth ( Frank, 2005 ).<br />

Syndromes resulting from GH excess are known to<br />

occur in the dog and the cat. In both species, the GH excess<br />

gives rise to outgrowth <strong>of</strong> bone and s<strong>of</strong>t tissues (acromegaly),<br />

as well as to insulin resistance with the possibility<br />

<strong>of</strong> development <strong>of</strong> frank diabetes mellitus. However, the<br />

pathogenesis <strong>of</strong> the excessive GH secretion in these species<br />

is completely different. GH-producing canine pituitary<br />

adenomas are extremely rare and only reported once<br />

( Fracassi, 2007 ). A physiological, reversible form <strong>of</strong> extrapituitary<br />

GH secretion is found to be stimulated during

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!